ResMed Inc
Close on Nov 19, 2026Market cap $33.32BP/E 21.6Yield 1.01%
ResMed Global Devices — Constant Currency Growth YoY by Quarter
Global Devices — Constant Currency Growth YoY (%) (%)
ResMed Global Devices — Constant Currency Growth YoY: 6.0% in Q1 FY27, down 1.0 pts from a year earlier.
Where the Q1 FY27 figure comes from
“Net revenue from devices for the three months ended September 30, 2026 increased to $720 million from $680 million for the three months ended September 30, 2025, an increase of $40 million or 6%, including an increase of 6% in the Americas and an increase of 6% in Rest of World (a 6% increase on a constant currency basis). Excluding the impact of foreign currency movements, device sales for the three months ended September 30, 2026 increased by 6”
Source: ResMed SEC Filing (0000943819-26-000089) ↗
Reported in ResMed Form 8-K & Form 10-Q MD&A Revenue Tables.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Global Devices — Constant Currency Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q1 FY27CQ3 2026 | Sep 30, 2026 | 6.0% | -1.0 pts | ResMed SEC Filing (0000943819-26-000089) ↗ |
| Q4 FY26CQ2 2026 | Jun 30, 2026 | 7.0% | -1.0 pts | ResMed SEC Filing (0001193125-26-337962) ↗ |
| Q3 FY26CQ1 2026 | Mar 31, 2026 | 6.0% | -1.0 pts | ResMed SEC Filing (0001193125-26-197192) ↗ |
| Q2 FY26CQ4 2025 | Dec 31, 2025 | 7.0% | -4.0 pts | ResMed SEC Filing (0001193125-26-029326) ↗ |
| Q1 FY26CQ3 2025 | Sep 30, 2025 | 7.0% | -3.0 pts | ResMed SEC Filing (0001193125-25-258519) ↗ |
| Q4 FY25CQ2 2025 | Jun 30, 2025 | 8.0% | +2.0 pts | ResMed SEC Filing (0001193125-25-170512) ↗ |
| Q3 FY25CQ1 2025 | Mar 31, 2025 | 7.0% | +2.0 pts | ResMed SEC Filing (0001193125-25-091357) ↗ |
| Q2 FY25CQ4 2024 | Dec 31, 2024 | 11.0% | 0.0 pts | ResMed SEC Filing (0001193125-25-017218) ↗ |
| Q1 FY25CQ3 2024 | Sep 30, 2024 | 10.0% | +2.0 pts | ResMed SEC Filing (0001193125-24-242806) ↗ |
| Q4 FY24CQ2 2024 | Jun 30, 2024 | 6.0% | -18.0 pts | ResMed SEC Filing (0001193125-24-191487) ↗ |
| Q3 FY24CQ1 2024 | Mar 31, 2024 | 5.0% | -38.0 pts | ResMed SEC Filing (0001193125-24-113883) ↗ |
| Q2 FY24CQ4 2023 | Dec 31, 2023 | 11.0% | -14.0 pts | ResMed SEC Filing (0001193125-24-014223) ↗ |
| Q1 FY24CQ3 2023 | Sep 30, 2023 | 8.0% | -1.0 pts | ResMed SEC Filing (0001193125-23-264072) ↗ |
| Q4 FY23CQ2 2023 | Jun 30, 2023 | 24.0% | +18.0 pts | ResMed SEC Filing (0001193125-23-202850) ↗ |
| Q3 FY23CQ1 2023 | Mar 31, 2023 | 43.0% | +22.0 pts | ResMed SEC Filing (0001193125-23-122110) ↗ |
| Q2 FY23CQ4 2022 | Dec 31, 2022 | 25.0% | +9.0 pts | ResMed SEC Filing (0001193125-23-016231) ↗ |
| Q1 FY23CQ3 2022 | Sep 30, 2022 | 9.0% | -22.0 pts | ResMed SEC Filing (0001193125-22-270961) ↗ |
| Q4 FY22CQ2 2022 | Jun 30, 2022 | 6.0% | – | ResMed SEC Filing (0001193125-22-218522) ↗ |
| Q3 FY22CQ1 2022 | Mar 31, 2022 | 21.0% | – | ResMed SEC Filing (0001193125-22-127535) ↗ |
| Q2 FY22CQ4 2021 | Dec 31, 2021 | 16.0% | – | ResMed SEC Filing (0001193125-22-019765) ↗ |
| Q1 FY22CQ3 2021 | Sep 30, 2021 | 31.0% | – | ResMed SEC Filing (0001193125-21-311286) ↗ |
Cite this data
StockData. (2026). ResMed Global Devices — Constant Currency Growth YoY (%), quarterly Q1 FY22–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-global-cc-yoy
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?